Jiménez-Ruiz, Carlos A <br/><br/>
Varenicline in smokers with severe or very severe COPD after 24 weeks of treatment. A descriptive analysis: VALUE study.  [electronic resource] 

 -  Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace  12 2017 
 - 874 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1122-0643 
<br/><br/><label>Standard No.: </label>10.4081/monaldi.2017.874  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Pulmonary Disease, Chronic Obstructive--drug therapy<br/>Smoking--adverse effects<br/>Smoking Cessation--methods<br/>Smoking Cessation Agents--therapeutic use<br/>Treatment Outcome<br/>Varenicline--administration & dosage